How to choose an antidepressant medication.

Published in: Acta psychiatrica Scandinavica (2019)

Clarification of AD choice would occur if medications are trialled in specific depressive subtypes rather than using the generic diagnosis of major depressive disorder (MDD). Such 'top-down' methods could be enhanced by 'bottom-up' studies to classify individuals according to symptom clusters and biomarkers with AD efficacy tested in these categories. Both methods could be utilised for personalised AD choice.

Keyphrases

major depressive disorder
bipolar disorder
healthcare
decision making
emergency department
case control
stress induced